Expression of pigment epithelium-derived factor in experimental choroidal neovascularization.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11980876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Age-Related Macular Degeneration

  2004cited by this paper
• Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

  2001cited by this paper
• Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.

  2001cited by this paper
• Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization.

  1999cited by this paper
• Four polymorphic variations in the PEDF gene identified during the mutation screening of patients with Leber congenital amaurosis.

  1999cited by this paper
• Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations.

  1999cited by this paper
• Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

  1999cited by this paper
• Vascular endothelial growth factor expression in choroidal neovascularization in rats

  1997cited by this paper
• [Intraocular neovascularization].

  1997cited by this paper
• Manipulating angiogenesis. From basic science to the bedside.

  1997cited by this paper
• Expression of vascular endothelial growth factor in experimental choroidal neovascularization

  1997influential reference
• Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Clinical applications of research on angiogenesis

  1996cited by this paper
• Localisation of a gene for central areolar choroidal dystrophy to chromosome 17p.

  1996cited by this paper
• The gene for PEDF, a retinal growth factor is a prime candidate for retinitis pigmentosa and is tightly linked to the RP13 locus on chromosome 17p13.3.

  1996cited by this paper
• Proteolytic activity directed toward pigment epithelium-derived factor in vitreous of bovine eyes. Implications of proteolytic processing.

  1996influential reference
• Analysis of EPC‐1 growth state–dependent expression, specificity, and conservation of related sequences

  1995cited by this paper
• A gene for autosomal dominant progressive cone dystrophy (CORD5) maps to chromosome 17p12-p13.

  1995cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity

  1995cited by this paper
• [Experimental choroidal neovascularization in the rat].

  1994cited by this paper
• The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.

  1992cited by this paper
• Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

  1992cited by this paper
• Tumor angiogenesis: the role of oncogenes and tumor suppressor genes.

  1990cited by this paper
• A model of subretinal neovascularization in the pigmented rat.

  1989influential reference
• A new model of experimental choroidal neovascularization in the rat.

  1989cited by this paper
• Age-related macular degeneration.

  1988cited by this paper
• Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity.

  1986cited by this paper
• Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity.

  1986cited by this paper
• Senile macular degeneration: a case-control study.

  1983cited by this paper
• Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration.

  1982cited by this paper
• The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

  1980cited by this paper

• Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review

  2024cites this paper
• Stem cell-based therapy for myopic maculopathy: a new concept

  2022cites this paper
• The biological relevance of pigment epithelium-derived factor on the path from aging to age-related disease.

  2021cites this paper
• Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization

  2020cites this paper
• Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor/p38 MAPK axis

  2020cites this paper
• Predictive Approach Identifies Molecular Targets and Interventions to Restore Angiogenesis in Wounds With Delayed Healing

  2019cites this paper
• The role of ADGRE5/CD97 in human retinal pigment epithelial cell growth and survival

  2019cites this paper
• Regulierbare somatische ex vivo Gentherapie zur Behandlung neurodegenerativer Erkrankungen mittels PEDF

  2017cites this paper
• EGFL 6 regulates hypoxia-induced angiogenic factors in retinal pigment epithelial cells

  2017cites this paper
• Short title Vasohibin family in the regulation of angiogenesis

  2016cites this paper
• Inhibition of choroidal neovascularization by lentivirus-mediated PEDF gene transfer in rats.

  2016cites this paper
• Biological Modulation of Mouse RPE Cells in Response to Subthreshold Diode Micropulse Laser Treatment

  2015cites this paper
• Pigment Epitel Kaynakli Faktör (PEDF): Çok Yönlü ve Fonksiyonlu Yeni Bir Terapötik Ajan Pigment Epithelium-Derived Factor (PEDF): A Multifaceted and Functional New Therapeutic Agent

  2015cites this paper
• Facultad de Medicina Departamento de Medicina

  2014cites this paper
• A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1

  2014cites this paper
• The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?

  2013influential citation
• Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice

  2013influential citation
• The isolation, characterisation and investigation into the in vitro behaviour of human ocular vascular endothelial cells

  2013cites this paper
• The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential

  2013cites this paper
• Clinical applications of retinal gene therapy.

  2013cites this paper
• New Pharmacologic Approaches to Therapy for Age-Related Macular Degeneration

  2012cites this paper
• Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept

  2012cites this paper
• Age-related macular degeneration

  2012cites this paper
• Angiostatic effect of CXCR3 expressed on choroidal neovascularization.

  2012cites this paper
• Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

  2011cites this paper
• Neue Therapieoptionen bei retinalen Erkrankungen: Was bringt die Zukunft?

  2011cites this paper
• Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration

  2011cites this paper
• Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration

  2011cites this paper
• Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization.

  2010cites this paper
• Pigment epithelium‐derived factor binds to cell‐surface F1‐ATP synthase

  2010cites this paper
• PEDF in angiogenic eye diseases.

  2010cites this paper
• Therapeutic targets in age-related macular disease.

  2010cites this paper
• Nouveaux traitements de la dégénérescence maculaire liée à l'âge

  2009cites this paper
• Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis.

  2009cites this paper
• Review of the Ocular Angiogenesis Animal Models

  2009cites this paper
• Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy

  2009cites this paper
• Mediators of ocular angiogenesis

  2009cites this paper
• Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration.

  2009cites this paper
• Octreotide Inhibits Choroidal Neovascularization in Rats

  2009cites this paper
• Antiangiogenic properties of silver nanoparticles.

  2009cites this paper
• Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration

  2009cites this paper
• The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.

  2008cites this paper
• Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration.

  2008cites this paper
• Pigment Epithelium-Derived Factor and Angiogenesis

  2008cites this paper
• Rodent Models of Oxygen-Induced Retinopathy

  2008cites this paper
• Clinical and Histological Aspects of CNV Formation: Studies in an Animal Model

  2008cites this paper
• Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy.

  2007cites this paper
• A new era in the treatment of age-related macular degeneration: from Factor X to antiangiogenesis

  2007cites this paper
• Anti-VEGF Therapies for Diseases of the Retina and Choroid

  2006cites this paper
• Molecular biology of choroidal neovascularization.

  2006cites this paper
• Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.

  2006cites this paper
• Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.

  2006cites this paper
• Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.

  2006cites this paper
• Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration.

  2006cites this paper
• Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor.

  2006cites this paper
• Pathological heterogeneity of vasoproliferative retinopathy in transgenic mice overexpressing vascular endothelial growth factor in photoreceptors.

  2006cites this paper
• Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.

  2006cites this paper
• Experimental Models of Macular Degeneration

  2005cites this paper
• Adeno-Associated Virus-Vectored Gene Therapy for Retinal Disease

  2005cites this paper
• Pharmacological Approaches to Age-Related Macular Degeneration

  2005cites this paper
• Clinical strategies for diagnosis and treatment of AMD: Implications from research

  2005cites this paper
• Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia.

  2005cites this paper
• Aetiology of Late Age-Related Macular Disease

  2005cites this paper
• Pathogénie des lésions de la dégénérescence maculaire liée à l’âge à un stade avancé

  2005cites this paper
• EFFICIENT GENE TRANSFER TO RETINAL PIGMENT EPITHELIUM CELLS WITH LONG-TERM EXPRESSION

  2005cites this paper
• STUDY OF INHIBITORY EFFECTS OF AN ANTIANGIOGENIC SOMATOSTATIN-CAMPTOTHECIN CONJUGATE ON LASER-INDUCED CHOROIDAL NEOVASCULARIZATION IN RATS

  2005cites this paper
• Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

  2004cites this paper
• [Pathogenesis of lesions in late age-related macular disease].

  2004cites this paper
• Anti-Vascular Endothelial Growth Factor Strategies for the Treatment of Choroidal Neovascularization From Age-Related Macular Degeneration

  2004cites this paper
• Development and pathology of the hyaloid, choroidal and retinal vasculature.

  2004cites this paper
• Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium

  2004cites this paper
• Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.

  2004cites this paper
• Pharmacological Therapy and Prophylaxis

  2004cites this paper
• IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407.

  2004cites this paper
• Pathogenesis of lesions in late age-related macular disease.

  2004cites this paper
• Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.

  2003cites this paper
• Die molekularen Mechanismender neovaskulären AMD

  2003cites this paper
• Status of therapies in development for the treatment of age-related macular degeneration.

  2003cites this paper
• In vivo gene transfer as a means to study the physiology and morphogenesis of the retinal pigment epithelium in the rat.

  2003cites this paper
• [Pharmacological therapy for age-related macular degeneration. Current developments and perspectives].

  2003cites this paper
• Pharmakologische Therapie der altersabhängigen Makuladegeneration

  2003influential citation
• Vascular endothelial growth factors and angiogenesis in eye disease.

  2003cites this paper
• Pathogenese der choroidalen Neovaskularisation

  2003cites this paper
• [The molecular mechanisms of neovascular age-related macular degeneration].

  2003cites this paper
• Predilection of the macular region to high incidence of choroidal neovascularization after intense laser photocoagulation in the monkey.

  2003cites this paper
• Role of growth factors and the wound healing response in age-related macular degeneration

  2003cites this paper
• Loss of pigment epithelium derived factor expression in glioma progression

  2003cites this paper
• [Pathogenesis of choroidal neovascularization. Old concepts, new questions].

  2003cites this paper
• Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism.

  2003cites this paper